|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.505 RUB | +10.15% |
|
-.--% | - |
| Market Cap | 135.61Cr 11TCr 117.88Cr 109.72Cr 100.74Cr 190.24Cr 13TCr 193.18Cr 1.29TCr 507.6Cr 6.44TCr 509.28Cr 498.09Cr 22TCr | P/E 2021 |
-2.42x | P/E 2022 | -6.53x |
|---|---|---|---|---|---|
| Enterprise Value | 209.23Cr 17TCr 181.88Cr 169.29Cr 155.43Cr 293.52Cr 20TCr 298.07Cr 2TCr 783.18Cr 9.94TCr 785.78Cr 768.52Cr 33TCr | EV / Sales 2021 |
5.43x | EV / Sales 2022 | 5.51x |
| Free-Float |
95.22% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | +10.15% |
| 5 years | 2.64 |  | 7 |
| 10 years | 2.64 | | 18.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 48 | 01/01/2014 | |
Alexey Shafranov
DFI | Director of Finance/CFO | 47 | - |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Dmitriy Genkin
CHM | Chairman | 57 | 01/01/2005 |
Indrek Kasela
BRD | Director/Board Member | 54 | 01/01/2007 |
Steve Gorelik
BRD | Director/Board Member | 47 | 01/01/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.15% | -.--% | -.--% | -.--% | 2.53Cr | |
| -0.53% | -3.95% | +50.70% | +153.56% | 1,02400Cr | |
| +0.21% | -2.68% | +53.20% | +51.79% | 62TCr | |
| -2.51% | -3.25% | +28.54% | +68.94% | 44TCr | |
| +0.06% | -0.42% | +37.53% | +30.67% | 35TCr | |
| -0.69% | -0.30% | +13.76% | +12.83% | 26TCr | |
| -7.37% | -4.40% | -0.74% | -44.28% | 21TCr | |
| -0.64% | +2.43% | +29.74% | +65.93% | 21TCr | |
| -0.82% | +0.70% | +15.05% | +72.05% | 16TCr | |
| +0.40% | +1.92% | +6.47% | -29.77% | 14TCr | |
| Average | -0.17% | -0.08% | +23.42% | +38.17% | 34.19TCr | |
| Weighted average by Cap. | -1.00% | -2.02% | +36.14% | +71.90% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 44Cr 3.48TCr 38Cr 35Cr 33Cr 61Cr 4.18TCr 62Cr 418.06Cr 164.08Cr 2.08TCr 164.62Cr 161Cr 6.99TCr | 38Cr 3.01TCr 33Cr 31Cr 28Cr 53Cr 3.62TCr 54Cr 362.11Cr 142.12Cr 1.8TCr 142.59Cr 139.46Cr 6.05TCr |
| Net income | -70Cr -5.53TCr -61Cr -56Cr -52Cr -98Cr -6.66TCr -99Cr -665.29Cr -261.11Cr -3.32TCr -261.97Cr -256.22Cr -11TCr | -21Cr -1.65TCr -18Cr -17Cr -15Cr -29Cr -1.98TCr -30Cr -197.9Cr -78Cr -986.1Cr -78Cr -76Cr -3.31TCr |
| Net Debt | 69Cr 5.49TCr 60Cr 56Cr 51Cr 97Cr 6.61TCr 99Cr 660.87Cr 259.37Cr 3.29TCr 260.23Cr 254.51Cr 11TCr | 74Cr 5.84TCr 64Cr 60Cr 55Cr 103.28Cr 7.03TCr 104.88Cr 702.18Cr 275.59Cr 3.5TCr 276.5Cr 270.43Cr 12TCr |
Employees
60
Sector
Pharmaceuticals
- Stock Market
- Stocks
- LIFE Stock
Select your edition
All financial news and data tailored to specific country editions
